K Robinson

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
    K Robinson
    Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA
    Circulation 94:2743-8. 1996
  2. ncbi Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group
    K Robinson
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 97:437-43. 1998
  3. ncbi Homocysteinemia and vascular disease in end-stage renal disease
    V W Dennis
    Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Ohio, USA
    Kidney Int Suppl 57:S11-7. 1996
  4. ncbi Hyperhomocysteinemia: detection, risk assessment, and treatment
    V W Dennis
    Department of Nephrology and Hypertension, Cleveland Clinic Foundation, OH 44195, USA
    Curr Opin Nephrol Hypertens 6:483-8. 1997
  5. ncbi Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease
    R Poddar
    Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 103:2717-23. 2001

Collaborators

Detail Information

Publications5

  1. ncbi Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
    K Robinson
    Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA
    Circulation 94:2743-8. 1996
    ..A high level of total plasma homocysteine is a risk factor for atherosclerosis, which is an important cause of death in renal failure. We evaluated the role of this as a risk factor for vascular complications of end-stage renal disease...
  2. ncbi Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group
    K Robinson
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 97:437-43. 1998
    ..This study was performed to explore the interrelationships between homocysteine, B vitamins, and vascular diseases and to evaluate the role of these vitamins as risk factors for atherosclerosis...
  3. ncbi Homocysteinemia and vascular disease in end-stage renal disease
    V W Dennis
    Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Ohio, USA
    Kidney Int Suppl 57:S11-7. 1996
    ..The mechanism by which high homocysteine concentrations might cause vascular damage in patients with renal failure remains unclear...
  4. ncbi Hyperhomocysteinemia: detection, risk assessment, and treatment
    V W Dennis
    Department of Nephrology and Hypertension, Cleveland Clinic Foundation, OH 44195, USA
    Curr Opin Nephrol Hypertens 6:483-8. 1997
    ..Current models favor direct angiotoxicity involving endothelial and vascular smooth muscle cells, and impaired thrombolysis. Folic acid reduces hyperhomocysteinemia and thus provides an opportunity for risk-factor modification...
  5. ncbi Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease
    R Poddar
    Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 103:2717-23. 2001
    ..This suggests that L-homocysteine may contribute to the initiation and progression of vascular disease by promoting leukocyte recruitment...